Literature DB >> 35273681

Effects and mechanism of miR-133a on invasion and migration of lung cancer cells.

Bing Yu1, Jinghua Pang1, Jiawen You1.   

Abstract

OBJECTIVES: To study the role of miR-133a expression in the invasion, proliferation, migration, and apoptosis of lung cancer cells and its mechanism.
METHODS: miR-133a expression levels in human normal lung epithelial cells (BEAS-2B), H441 cell lines and NSCLC tissues were detected by qPCR. The influence of miR-133a mimics on the migration, proliferation and invasion of H441 cells was examined by CCK-8 assay, transwell migration assay, and invasion assay, respectively. Expression of MMP-9 and LASP1 in H441 cellstreated by miR-133a mimics was determined by western blot. Pearson's test was conducted to study the association of miR-133a expression with clinical characteristics of NSCLC patients. The targeted regulation of miR-133a on LASP1 gene expression was detected by the luciferase reporter gene assay.
RESULTS: miR-133a expression was decreased in H441 cells in contrast to that in BEAS-2B cells (P<0.05). Compared with para-carcinoma tissues, miR-133a levels were markedly down-regulated in NSCLC tissues. miR-133a overexpression inhibited the invasion, proliferation, and migration ability of H441 cells and promoted cell apoptosis (all P<0.05). MMP-9 expression levels were also reduced in the miR-133a mimic group. Moreover, miR-133a expression levels were correlated with tumor size and TNM stage. miR-133a overexpression decreased the expression of LASP1, which is the targeted gene of miR-133a.
CONCLUSIONS: miR-133a overexpression can reduce the invasion, proliferation, migration, and matrix metalloproteinase expression of NSCLC cells and promote cell apoptosis. This may be correlated to targeted down-regulation of LASP1 expression. AJTR
Copyright © 2022.

Entities:  

Keywords:  NSCLC; invasion; matrix metalloproteinase; miR-133a; migration; proliferation

Year:  2022        PMID: 35273681      PMCID: PMC8902573     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  39 in total

1.  A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer.

Authors:  Yajie Zhang; Jack A Roth; Hao Yu; Yuanqing Ye; Kunlin Xie; Hua Zhao; David W Chang; Maosheng Huang; Hecheng Li; Jieming Qu; Xifeng Wu
Journal:  Carcinogenesis       Date:  2019-07-04       Impact factor: 4.944

2.  Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.

Authors:  Lisha Ying; Lingbin Du; Ruiyang Zou; Lei Shi; Nan Zhang; Jiaoyue Jin; Chenyang Xu; Fanrong Zhang; Chen Zhu; Junzhou Wu; Kaiyan Chen; Minran Huang; Yingxue Wu; Yimin Zhang; Weihui Zheng; Xiaodan Pan; Baofu Chen; Aifen Lin; John Kit Chung Tam; Rob Martinus van Dam; David Tien Min Lai; Kee Seng Chia; Lihan Zhou; Heng-Phon Too; Herbert Yu; Weimin Mao; Dan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-17       Impact factor: 11.205

Review 3.  Triple negative breast cancer in the era of miRNA.

Authors:  Hussein Sabit; Emre Cevik; Huseyin Tombuloglu; Shaimaa Abdel-Ghany; Guzin Tombuloglu; Manel Esteller
Journal:  Crit Rev Oncol Hematol       Date:  2020-12-09       Impact factor: 6.312

4.  Expression and clinical significance of MMP-9 and P53 in lung cancer.

Authors:  H Zhang; B Zhao; Z-G Zhai; J-D Zheng; Y-K Wang; Y-Y Zhao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-02       Impact factor: 3.507

5.  2020 Innovation-Based Optimism for Lung Cancer Outcomes.

Authors:  Erin L Schenk; Tejas Patil; Jose Pacheco; Paul A Bunn
Journal:  Oncologist       Date:  2020-12-20

6.  Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.

Authors:  Noemí García-Magallanes; Saúl Armando Beltran-Ontiveros; Emir Adolfo Leal-León; Fred Luque-Ortega; José Geovanni Romero-Quintana; Ignacio Osuna-Ramirez; María Barbosa-Jasso; Eliakym Arámbula-Meraz
Journal:  J Cancer Res Ther       Date:  2020 Oct-Dec       Impact factor: 1.805

7.  Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.

Authors:  Johannes F Fahrmann; Dmitry Grapov; Brett S Phinney; Carol Stroble; Brian C DeFelice; William Rom; David R Gandara; Yanhong Zhang; Oliver Fiehn; Harvey Pass; Suzanne Miyamoto
Journal:  Clin Proteomics       Date:  2016-10-27       Impact factor: 3.988

8.  Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

Authors:  Sonia Blanco-Prieto; Leticia Barcia-Castro; María Páez de la Cadena; Francisco Javier Rodríguez-Berrocal; Lorena Vázquez-Iglesias; María Isabel Botana-Rial; Alberto Fernández-Villar; Loretta De Chiara
Journal:  BMC Cancer       Date:  2017-12-05       Impact factor: 4.430

9.  p21-activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1.

Authors:  Hui Huang; Qianqian Xue; Xiaoge Du; Jie Cui; Jing Wang; Dan Cheng; Jiaqiong Li; Yaqiu Zheng; Guojing Huang; Keke Zhang; Kangdong Liu; Jing Lu; Jimin Zhao; Xinhuan Chen; Ziming Dong; Xiang Li
Journal:  Mol Carcinog       Date:  2020-12-01       Impact factor: 4.784

10.  miR-133a-5p suppresses gastric cancer through TCF4 down-regulation.

Authors:  Mu-Qun He; Jian-Feng Wan; Hong-Fu Zeng; Ying-Yan Tang; Mu-Qing He
Journal:  J Gastrointest Oncol       Date:  2021-06
View more
  1 in total

1.  miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.

Authors:  Kang Zhang; Xiaoliang Han; Wenbin Hu; Chao Su; Binjun He
Journal:  Oncol Lett       Date:  2022-09-12       Impact factor: 3.111

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.